Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03647046 · ClinicalTrials.gov registry record · NA
Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03647046: Completed NA study, sponsored by University of Rochester.
NCT03647046 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03647046, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of the study is to examine the effects of custom front-surface wavefront correction on visual performance, and on neutralization of higher order aberrations, in patients wearing a scleral lens device. The investigators will study patients with keratoconus, the most common type of corneal ectasia, who have already been fitted with the BostonSight BSS (Boston Sight Scleral) for improved visual function.
Primary Outcome
Vision will be tested using the Basic Snellen Visual Acuity test and normal vision will be defined as 20/20.
Interventions
- DEVICE Customized Scleral Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-10-08 |
| Est. Completion | 2020-01-20 |
| Phase | NA |
What the finished NCT03647046 record still lists
NCT03647046 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Customized Scleral Lens is the first listed.
NCT03647046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03647046 about?
NCT03647046 is a clinical study titled "Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus". The goal of the study is to examine the effects of custom front-surface wavefront correction on visual performance, and on neutralization of higher order aberrations, in patients wearing a scleral lens device. The investigators will study patients with keratoconus, the most common type of corneal ec...
What is the current status of trial NCT03647046?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-10-08. Estimated completion is 2020-01-20.
What interventions are being tested in trial NCT03647046?
The interventions under investigation include: Customized Scleral Lens (DEVICE).
Who is sponsoring clinical trial NCT03647046?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03647046's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI